| |
| |
|
| Insider
Information: |
Reed Vickie S |
| Relationship: |
|
| City: |
San Diego |
| State: |
CA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
1 |
|
| Direct
Shares |
15,369 |
|
|
Indirect Shares
|
0 |
|
|
| Direct
Value |
$902,160 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
15,369 |
|
|
| Total
Value |
$902,160 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
|
|
| Stock
price went down : |
|
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Mirati Therapeutics, Inc. |
MRTX |
|
2022-01-18 |
15,369 |
2020-01-06 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
8 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 1
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| MRTX |
Mirati Therapeutics, Inc. |
SVP, Chief Accounting Officer |
• – – |
2022-01-18 |
4 |
S |
$120.48 |
$64,217 |
D/D |
(533) |
15,369 |
0 |
% |
|
| MRTX |
Mirati Therapeutics, Inc. |
SVP, Chief Accounting Officer |
• – – |
2022-01-14 |
4 |
A |
$0.00 |
$0 |
D/D |
5,377 |
15,902 |
0 |
- |
|
| MRTX |
Mirati Therapeutics, Inc. |
SVP, Chief Accounting Officer |
• – – |
2022-01-07 |
4 |
S |
$135.94 |
$46,900 |
D/D |
(345) |
10,525 |
0 |
% |
|
| MRTX |
Mirati Therapeutics, Inc. |
SVP, Chief Accounting Officer |
• – – |
2022-01-04 |
4 |
S |
$147.74 |
$111,987 |
D/D |
(758) |
10,870 |
0 |
% |
|
| MRTX |
Mirati Therapeutics, Inc. |
SVP, Chief Accounting Officer |
• – – |
2021-01-15 |
4 |
A |
$0.00 |
$0 |
D/D |
4,157 |
11,628 |
0 |
- |
|
| MRTX |
Mirati Therapeutics, Inc. |
SVP, Chief Accounting Officer |
• – – |
2021-01-07 |
4 |
S |
$216.33 |
$52,135 |
D/D |
(241) |
7,471 |
0 |
% |
|
| MRTX |
Mirati Therapeutics, Inc. |
SVP, Chief Accounting Officer |
• – – |
2021-01-06 |
4 |
S |
$210.28 |
$113,190 |
D/D |
(538) |
7,712 |
0 |
% |
|
| MRTX |
Mirati Therapeutics, Inc. |
SVP, Chief Accounting Officer |
• – – |
2020-01-06 |
4 |
A |
$0.00 |
$0 |
D/D |
2,750 |
8,250 |
0 |
- |
|
8 Records found
|
1
|
Page 1 of 1 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
